2-methoxy-4-(5-(trifluoromethyl)benzo[d]thiazol-2-yl)phenol | 1393370-77-8

• 分子结构分类: 有机化合物 - 苯类化合物
• 英文名称: 2-methoxy-4-(5-(trifluoromethyl)benzo[d]thiazol-2-yl)phenol
• 英文别名: 2-methoxy-4-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]phenol
• CAS: 1393370-77-8
• 化学式: C₁₅H₁₀F₃NO₂S
• 分子量: 325.311
• InChiKey: KQSHQDNEIPALMK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  70.6
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  2-氨基-4-(三氟甲基)-苯硫醇 、 香草醛 在 sodium metabisulfite 作用下， 以 二甲基亚砜 为溶剂， 以22%的产率得到2-methoxy-4-(5-(trifluoromethyl)benzo[d]thiazol-2-yl)phenol
  参考文献：
  名称：

  A Fluorinated Phenylbenzothiazole Arrests the Trypanosoma cruzi Cell Cycle and Diminishes the Infection of Mammalian Host Cells

  摘要：

  恰加斯病（CD）是一种由以下病原体引起的人类传染病 克鲁斯 Trypanosoma cruzi .南美锥虫病传统上流行于美洲，但由于人口迁移，该病已蔓延到非流行区的国家。目前治疗 CD 的化疗方法会产生多种副作用，而且其在疾病慢性期的疗效也存在争议。本研究合成了取代的苯基苯并噻唑衍生物，并对其进行了生物评估，认为其可作为杀灭克鲁病锥虫的药物。 克鲁斯锥虫 .

  DOI：

  10.1128/aac.01742-19

文献信息

• NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR
  申请人：Chung Hae Young

  公开号：US20140037564A1

  公开（公告）日：2014-02-06

  Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPARα and PPARγ activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.

  提供了一种具有美白皮肤、抗氧化和PPAR活性的新化合物及其医药用途，该化合物具有抑制酪氨酸酶的美白皮肤活性，因此适用于用于美白皮肤的药用组合物或化妆品；具有抗氧化活性，因此适用于预防和治疗皮肤衰老；具有PPAR活性，特别是PPARα和PPARγ活性，因此适用于用于预防和治疗肥胖、代谢性疾病或心血管疾病的药用组合物或保健食品。
• NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF
  申请人：Pusan National University Industry-University Cooperation Foundation

  公开号：US20150366776A1

  公开（公告）日：2015-12-24

  Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPARα and PPARγ activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.

  提供了一种具有美白、抗氧化和PPAR活性的新化合物及其医疗用途，该化合物具有抑制酪氨酸酶的美白活性，因此可用于美白药物或化妆品产品；具有抗氧化活性，因此可用于预防和治疗皮肤衰老；具有PPAR活性，特别是PPARα和PPARγ活性，因此可用于制备有效预防和治疗肥胖症、代谢性疾病或心血管疾病的药物组合物或保健食品。
• US8889881B2
  申请人：——

  公开号：US8889881B2

  公开（公告）日：2014-11-18
• US9155690B2
  申请人：——

  公开号：US9155690B2

  公开（公告）日：2015-10-13
• [EN] NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR<br/>[FR] NOUVEAU COMPOSÉ À ACTIVITÉS DE BLANCHIMENT DE LA PEAU, ANTI-OXYDANTE POUR LA PEAU ET PPAR ET UTILISATION MÉDICALE CORRESPONDANTE
  申请人：PUSAN NAT UNIVERSITY INDUSTRYUNIVERSITY

  公开号：WO2012108689A2

  公开（公告）日：2012-08-16

  본 발명은 피부미백, 항산화 및 PPAR 활성을 갖는 신규 화합물 및 이의 의학적 용도에 관한 것으로, 본 발명에 따른 화합물들은 티로시나아제를 억제하는 피부미백 활성을 지니므로 피부미백용 약학조성물 또는 화장품에 유용하게 사용될 수 있고, 항산화 활성을 지니므로 피부노화 등의 예방 또는 치료에 유용하게 사용될 수 있으며, 또한 PPAR 활성 특히, PPARα 및 PPARγ 활성을 지니므로 비만, 대사성 질환 또는 심혈관계 질환을 예방하고 치료하는 데에 유용한 약학조성물 또는 건강식품으로 사용될 수 있다.